Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5889 ARTÍCULOS , VIENDO DEL 3016 AL 3030

Episodic ataxia associated with a de novo SCN2A mutation

Leach EL, van Karnebeek CD, Townsend KN, Tarailo-Graovac M, Hukin J, Gibson WT.

Eur J Paediatr Neurol. 2016 Sep;20(5):772-6. doi: 10.1016/j.ejpn.2016.05.020. Epub 2016 Jun 14.

Two Siblings with Adolescent/Adult Onset Niemann-Pick Disease Type C in Korea

Lee SY, Lee HJ, Kim SH, Jeong YJ, Jin HK, Bae JS, Cheon SM, Kim JW.

J Korean Med Sci. 2016 Jul;31(7):1168-72. doi: 10.3346/jkms.2016.31.7.1168. Epub 2016 May 12.

Insights into the Pathology of the α3 Na(+)/K(+)-ATPase Ion Pump in Neurological Disorders; Lessons from Animal Models

Holm TH, Lykke-Hartmann K.

Front Physiol. 2016 Jun 14;7:209. doi: 10.3389/fphys.2016.00209. eCollection 2016.

Dystonia in a Patient with Autosomal-Dominant Progressive External Ophthalmoplegia Type 1 Caused by Mutation in the POLG Gene

Rossi M, Medina Escobar A, Radrizzani M, Tenembaum S, Perandones C, Merello M.

Mov Disord Clin Pract. 2016 Jul 8;4(2):266-269. doi: 10.1002/mdc3.12397. eCollection 2017 Mar-Apr.

Brain Metabolic Changes of Cervical Dystonia with Spinocerebellar Ataxia Type 1 after Botulinum Toxin Therapy

Kikuchi A, Takeda A, Sugeno N, Miura E, Kato K, Hasegawa T, Baba T, Konno M, Oshima R, Watanuki S, Hiraoka K, Tashiro M, Aoki M.

Intern Med. 2016;55(14):1919-22. doi: 10.2169/internalmedicine.55.5843. Epub 2016 Jul 15.

Movement disorders in mitochondrial diseases

Tranchant C, Anheim M.

Rev Neurol (Paris). 2016 Aug-Sep;172(8-9):524-529. doi: 10.1016/j.neurol.2016.07.003. Epub 2016 Jul 28.

More Than Ataxia: Hyperkinetic Movement Disorders in Childhood Autosomal Recessive Ataxia Syndromes

Pearson TS.

Tremor Other Hyperkinet Mov (N Y). 2016 Jul 16;6:368. doi: 10.7916/D8H70FSS. eCollection 2016.

Cerebellar transcranial direct current stimulation in neurological disease

Ferrucci R, Bocci T, Cortese F, Ruggiero F, Priori A.

Cerebellum Ataxias. 2016 Sep 2;3(1):16. doi: 10.1186/s40673-016-0054-2. eCollection 2016.

De novo p.Arg756Cys mutation of ATP1A3 causes an atypical form of alternating hemiplegia of childhood with prolonged paralysis and choreoathetosis

Kanemasa H, Fukai R, Sakai Y, Torio M, Miyake N, Lee S, Ono H, Akamine S, Nishiyama K, Sanefuji M, Ishizaki Y, Torisu H, Saitsu H, Matsumoto N, Hara T.

BMC Neurol. 2016 Sep 15;16:174. doi: 10.1186/s12883-016-0680-6.

A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder

Garone C, Gurgel-Giannetti J, Sanna-Cherchi S, Krishna S, Naini A, Quinzii CM, Hirano M.

J Child Neurol. 2017 Feb;32(2):246-250. doi: 10.1177/0883073816666221. Epub 2016 Sep 28.

Dystonia in ATP2B3-associated X-linked spinocerebellar ataxia

Feyma T, Ramsey K; C4RCD Research Group; Huentelman MJ, Craig DW, Padilla-Lopez S, Narayanan V, Kruer MC.

Mov Disord. 2016 Nov;31(11):1752-1753. doi: 10.1002/mds.26800. Epub 2016 Sep 22.

Applications of CRISPR/Cas9 for Gene Editing in Hereditary Movement Disorders

Im W, Moon J, Kim M.

J Mov Disord. 2016 Sep;9(3):136-43. doi: 10.14802/jmd.16029. Epub 2016 Sep 21.

Writer's cramp in spinocerebellar ataxia Type 1

Khwaja GA, Srivastava A, Ghuge VV, Chaudhry N.

J Neurosci Rural Pract. 2016 Oct-Dec;7(4):584-586. doi: 10.4103/0976-3147.186980.

Mosaicism in ATP1A3-related disorders: not just a theoretical risk

Hully M, Ropars J, Hubert L, Boddaert N, Rio M, Bernardelli M, Desguerre I, Cormier-Daire V, Munnich A, de Lonlay P, Reilly L, Besmond C, Bahi-Buisson N.

Neurogenetics. 2017 Jan;18(1):23-28. doi: 10.1007/s10048-016-0498-9. Epub 2016 Oct 10.

Baclofen Toxicity in a Patient with Hemodialysis-Dependent End-Stage Renal Disease

Porter LM, Merrick SS, Katz KD.

J Emerg Med. 2017 Apr;52(4):e99-e100. doi: 10.1016/j.jemermed.2016.09.025. Epub 2016 Oct 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias